GO
| HSI1 | 25,606.03 | +219.51 | 281.30B |
| HSCEI1 | 8,550.87 | +75.55 | 91.73B |
| Back Zoom + Zoom - Block Traded | |
|
2026-05-21 14:54:29 ALI HEALTH (00241.HK) launched the "Hydrion" app, positioning it as an early AI pioneer targeting doctors, in collaboration with The BMJ to provide evidence-based clinical decision support, Jefferies said in its report. Initial product testing shows strong usability, a low hallucination rate and robust clinical reasoning. Management expects to invest RMB200-300 million annually in AI R&D during FY2027-29, targeting 2 million MAUs within three years and aiming for "Hydrion" to achieve breakeven in 2029. As a leading B2C participant, ALI HEALTH's internet hospital workflow has been officially authorized and is largely unaffected by recent news regarding tightened GLP-1 prescription restrictions in Jiangxi and Shanghai. The broker lowered its TP on ALI HEALTH from HKD6 to HKD5.3 to reflect uncertainties such as commercialization pace, but maintained its Buy rating. ~ AASTOCKS Financial News Website: www.aastocks.com | |